Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial.
Yoon CH, Ross MI, Gastman BR, Luke JJ, Ascierto PA, Long GV, Rutkowski P, Khattak M, Del Vecchio M, de la Cruz Merino L, Mackiewicz J, Chiarion-Sileni V, Schadendorf D, Carlino MS, Zhao Y, Fukunaga-Kalabis M, Krepler C, Eggermont AMM, Gershenwald JE, Sondak VK.
Yoon CH, et al. Among authors: zhao y.
Ann Surg Oncol. 2025 Feb 1. doi: 10.1245/s10434-024-16642-6. Online ahead of print.
Ann Surg Oncol. 2025.
PMID: 39893343